LIRA-PRIME: a randomised trial in primary care settings of liraglutide versus OAD for glycaemic control in patients with type 2 diabetes not in control on metformin

Basit Öğe Kaydı
dc.contributor.authorZoghbi, M.
dc.contributor.authorKaltoft, M. S.
dc.contributor.authorKolhe, D.
dc.contributor.authorPanda, J. K.
dc.contributor.authorSargin, M.
dc.contributor.authorWolthers, B.
dc.contributor.authorUnger, J.
dc.date.accessioned2025-05-10T19:32:43Z
dc.date.issued2020
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) -- SEP 21-25, 2020 -- ELECTR NETWORK
dc.description.abstract[No abstract available]
dc.description.sponsorshipEuropean Assoc Study Diabet
dc.description.sponsorshipNovo Nordisk A/S
dc.description.sponsorshipSupported by: Novo Nordisk A/S
dc.identifier.endpageS286
dc.identifier.issn0012-186X
dc.identifier.issn1432-0428
dc.identifier.issueSUPPL 1
dc.identifier.scopusqualityQ1
dc.identifier.startpageS285
dc.identifier.urihttps://hdl.handle.net/20.500.14730/8336
dc.identifier.volume63
dc.identifier.wosWOS:000565776600594
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofDiabetologia
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleLIRA-PRIME: a randomised trial in primary care settings of liraglutide versus OAD for glycaemic control in patients with type 2 diabetes not in control on metformin
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu